Genedx Holdings Corp Stock Current Valuation
| WGS Stock | 104.39 7.68 7.94% |
Valuation analysis of GeneDx Holdings Corp helps investors to measure GeneDx Holdings' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that GeneDx Holdings' price fluctuation is very steady at this time. Calculation of the real value of GeneDx Holdings Corp is based on 3 months time horizon. Increasing GeneDx Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GeneDx stock is determined by what a typical buyer is willing to pay for full or partial control of GeneDx Holdings Corp. Since GeneDx Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GeneDx Stock. However, GeneDx Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 104.39 | Real 84.71 | Hype 110.98 | Naive 104.68 |
The intrinsic value of GeneDx Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence GeneDx Holdings' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of GeneDx Holdings Corp helps investors to forecast how GeneDx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GeneDx Holdings more accurately as focusing exclusively on GeneDx Holdings' fundamentals will not take into account other important factors: GeneDx Holdings Corp Company Current Valuation Analysis
GeneDx Holdings' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current GeneDx Holdings Current Valuation | 2.71 B |
Most of GeneDx Holdings' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeneDx Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, GeneDx Holdings Corp has a Current Valuation of 2.71 B. This is 81.13% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 83.7% higher than that of the company.
GeneDx Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GeneDx Holdings' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GeneDx Holdings could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics of similar companies.GeneDx Holdings is currently under evaluation in current valuation category among its peers.
GeneDx Fundamentals
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.032 | ||||
| Profit Margin | (0.17) % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 2.71 B | ||||
| Shares Outstanding | 28.07 M | ||||
| Shares Owned By Insiders | 12.71 % | ||||
| Shares Owned By Institutions | 87.98 % | ||||
| Number Of Shares Shorted | 2.75 M | ||||
| Price To Book | 11.15 X | ||||
| Price To Sales | 8.89 X | ||||
| Revenue | 305.45 M | ||||
| Gross Profit | 194.45 M | ||||
| EBITDA | (23.21 M) | ||||
| Net Income | (52.29 M) | ||||
| Total Debt | 64.25 M | ||||
| Book Value Per Share | 8.75 X | ||||
| Cash Flow From Operations | (28.5 M) | ||||
| Short Ratio | 1.78 X | ||||
| Earnings Per Share | (1.94) X | ||||
| Target Price | 107.33 | ||||
| Number Of Employees | 1 K | ||||
| Beta | 1.98 | ||||
| Market Capitalization | 2.71 B | ||||
| Total Asset | 419.38 M | ||||
| Retained Earnings | (1.35 B) | ||||
| Working Capital | 143.15 M | ||||
| Net Asset | 419.38 M |
About GeneDx Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GeneDx Holdings Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneDx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneDx Holdings Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.